BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28670493)

  • 1. MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting
    Jiang T; Guan LY; Ye YS; Liu HY; Li R
    Am J Cancer Res; 2017; 7(6):1310-1321. PubMed ID: 28670493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
    Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
    Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
    Cao J; Liu J; Long J; Fu J; Huang L; Li J; Liu C; Zhang X; Yan Y
    Biomed Pharmacother; 2017 May; 89():642-650. PubMed ID: 28262617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.
    Sun K; Zeng T; Huang D; Liu Z; Huang S; Liu J; Qu Z
    FEBS Open Bio; 2015; 5():900-7. PubMed ID: 26697292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.
    Yu S; Jing L; Yin XR; Wang MC; Chen YM; Guo Y; Nan KJ; Han LL
    Oncotarget; 2017 Nov; 8(59):99757-99771. PubMed ID: 29245938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma.
    Lu J; Lin Y; Li F; Ye H; Zhou R; Jin Y; Li B; Xiong X; Cheng N
    FASEB J; 2018 May; ():fj201800113R. PubMed ID: 29799789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-96-5p induces the epithelial-mesenchymal transition to promote the metastasis of hepatocellular carcinoma by post-transcriptionally downregulating Talin 1.
    Tang H; Liu Y; Cheng W; He Z; Zhou N
    Int J Clin Exp Pathol; 2019; 12(5):1897-1908. PubMed ID: 31934013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
    Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells.
    Liu Z; Wang J; Mao Y; Zou B; Fan X
    Oncol Lett; 2016 Jan; 11(1):433-438. PubMed ID: 26870229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.